Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07492667
What this trial is testing

Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life

Who this might be right for
Event Suggestive of Multiple SclerosisMultiple Sclerosis
Central Hospital, Nancy, France 100
Not applicableActive Not RecruitingNCT05124522
What this trial is testing

A Health Action Process Approach Online Intervention for People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Illinois at Urbana-Champaign 60
Not applicableUnknownNCT04874051
What this trial is testing

Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases

Who this might be right for
StrokeMultiple SclerosisParkinson Disease
IRCCS San Camillo, Venezia, Italy 120
Not applicableStudy completedNCT00142402
What this trial is testing

Modafinil in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Kessler Foundation 20
Not applicableActive Not RecruitingNCT04126772
What this trial is testing

Multimodal Imaging of MS Reveals the Smoldering Inflammation

Who this might be right for
Multiple Sclerosis
Turku University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02495766
What this trial is testing

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Banc de Sang i Teixits 8
Not applicableStudy completedNCT03500328
What this trial is testing

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Johns Hopkins University 900
Not applicableStudy completedNCT05225012
What this trial is testing

Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2

Who this might be right for
Multiple Sclerosis
University of Nottingham 5
Not applicableUnknownNCT06231030
What this trial is testing

Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) Turkish Adaptation

Who this might be right for
Multiple SclerosisSelf Efficacy
Nigde Omer Halisdemir University 120
Not applicableEnrolling By InvitationNCT06879665
What this trial is testing

TANDem-2: Closing the Gap to Interventions for TAND

Who this might be right for
Adult Caregivers of Individuals With TSCTuberous Sclerosis Complex (TSC)
Vrije Universiteit Brussel 30
Testing effectiveness (Phase 2)Study completedNCT01305837
What this trial is testing

Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Rigshospitalet, Denmark 30
Not applicableStudy completedNCT06891937
What this trial is testing

Self-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital 30
Not applicableActive Not RecruitingNCT07593807
What this trial is testing

TMS Combined With Virtual Reality and Multidisciplinary Rehabilitation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Sao Paulo 30
Large-scale testing (Phase 3)Looking for participantsNCT06846281
What this trial is testing

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 400
Early research (Phase 1)Not Yet RecruitingNCT06607900
What this trial is testing

HUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+3 more
Xuanwu Hospital, Beijing 120
Early research (Phase 1)Ended earlyNCT01028209
What this trial is testing

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Who this might be right for
Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Institute for Neurodegenerative Disorders 12
Not applicableStudy completedNCT01491100
What this trial is testing

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 1,085
Testing effectiveness (Phase 2)Active Not RecruitingNCT06564311
What this trial is testing

Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Who this might be right for
Relapsing Multiple Sclerosis
Zenas BioPharma (USA), LLC 93
Not applicableStudy completedNCT04533971
What this trial is testing

The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (ICD10-G35)
Pomeranian Medical University Szczecin 114
Not applicableActive Not RecruitingNCT07538063
What this trial is testing

Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity

Who this might be right for
Multiple Sclerosis
Hunter College of City University of New York 50
Next Page